Preventing Postoperative Recurrence in Crohn’s Disease: What Does the Future Hold? Lucine VuittonStéphane KochLaurent Peyrin-Biroulet Current Opinion 17 October 2013 Pages: 1749 - 1759
Current Management of Iron Deficiency Anemia in Inflammatory Bowel Diseases: A Practical Guide Fernando GomollónJavier P. Gisbert Therapy in Practice 11 October 2013 Pages: 1761 - 1770
Current and Emerging Options for the Drug Treatment of Narcolepsy Alberto K. De la Herrán-AritaFabio García-García Review Article 12 October 2013 Pages: 1771 - 1781
Alternative Delivery Systems for Agents to Treat Acute Agitation: Progress to Date Kimberly NordstromMichael H. Allen Review Article 23 October 2013 Pages: 1783 - 1792
Immunosuppression and Allograft Rejection Following Lung Transplantation: Evidence to Date Gregory I. SnellGlen P. WestallMiranda A. Paraskeva Review Article 19 October 2013 Pages: 1793 - 1813
Tobramycin Inhalation Powder: A Review of Its Use in the Treatment of Chronic Pseudomonas aeruginosa Infection in Patients with Cystic Fibrosis Kate McKeage Adis Drug Evaluation 06 November 2013 Pages: 1815 - 1827
Telavancin: A Review of Its Use in Patients with Nosocomial Pneumonia Lesley J. Scott Adis Drug Evaluation 05 November 2013 Pages: 1829 - 1839
Olodaterol: First Global Approval Andrew GibbLily P. H. Yang R&D Insight Report 26 October 2013 Pages: 1841 - 1846
Erratum to: Canagliflozin: First Global Approval Shelley ElkinsonLesley J. Scott Erratum 30 October 2013 Pages: 1847 - 1847